Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations
Objective: To compare the current rate of antibiotic prescribing for acute respiratory infections (ARIs) in Australian general practice with the recommendations in the most widely consulted therapeutic guidelines in Australia (Therapeutic Guidelines). Design and setting: Comparison of general practi...
Uložené v:
| Vydané v: | Medical journal of Australia Ročník 207; číslo 2; s. 65 - 69 |
|---|---|
| Hlavní autori: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Australia
17.07.2017
|
| Predmet: | |
| ISSN: | 0025-729X, 1326-5377, 1326-5377 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Objective: To compare the current rate of antibiotic prescribing for acute respiratory infections (ARIs) in Australian general practice with the recommendations in the most widely consulted therapeutic guidelines in Australia (Therapeutic Guidelines).
Design and setting: Comparison of general practice activity data for April 2010 – March 2015 (derived from Bettering the Evaluation and Care of Health [BEACH] study) with estimated rates of prescribing recommended by Therapeutic Guidelines.
Main outcome measures: Antibiotic prescribing rates and estimated guideline‐recommended rates per 100 encounters and per full‐time equivalent (FTE) GP per year for eight ARIs; number of prescriptions nationally per year.
Results: An estimated mean 5.97 million (95% CI, 5.69–6.24 million) ARI cases per year were managed in Australian general practice with at least one antibiotic, equivalent to an estimated 230 cases per FTE GP/year (95% CI, 219–240 cases/FTE/year). Antibiotics are not recommended by the guidelines for acute bronchitis/bronchiolitis (current prescribing rate, 85%) or influenza (11%); they are always recommended for community‐acquired pneumonia (current prescribing rate, 72%) and pertussis (71%); and they are recommended for 0.5–8% of cases of acute rhinosinusitis (current prescribing rate, 41%), 20–31% of cases of acute otitis media (89%), and 19–40% cases of acute pharyngitis or tonsillitis (94%). Had GPs adhered to the guidelines, they would have prescribed antibiotics for 0.65–1.36 million ARIs per year nationally, or at 11–23% of the current prescribing rate. Antibiotics were prescribed more frequently than recommended for acute rhinosinusitis, acute bronchitis/bronchiolitis, acute otitis media, and acute pharyngitis/tonsillitis.
Conclusions: Antibiotics are prescribed for ARIs at rates 4–9 times as high as those recommended by Therapeutic Guidelines. Our data provide the basis for setting absolute targets for reducing antibiotic prescribing in Australian general practice. |
|---|---|
| AbstractList | To compare the current rate of antibiotic prescribing for acute respiratory infections (ARIs) in Australian general practice with the recommendations in the most widely consulted therapeutic guidelines in Australia (Therapeutic Guidelines).
Comparison of general practice activity data for April 2010 - March 2015 (derived from Bettering the Evaluation and Care of Health [BEACH] study) with estimated rates of prescribing recommended by Therapeutic Guidelines.
Antibiotic prescribing rates and estimated guideline-recommended rates per 100 encounters and per full-time equivalent (FTE) GP per year for eight ARIs; number of prescriptions nationally per year.
An estimated mean 5.97 million (95% CI, 5.69-6.24 million) ARI cases per year were managed in Australian general practice with at least one antibiotic, equivalent to an estimated 230 cases per FTE GP/year (95% CI, 219-240 cases/FTE/year). Antibiotics are not recommended by the guidelines for acute bronchitis/bronchiolitis (current prescribing rate, 85%) or influenza (11%); they are always recommended for community-acquired pneumonia (current prescribing rate, 72%) and pertussis (71%); and they are recommended for 0.5-8% of cases of acute rhinosinusitis (current prescribing rate, 41%), 20-31% of cases of acute otitis media (89%), and 19-40% cases of acute pharyngitis or tonsillitis (94%). Had GPs adhered to the guidelines, they would have prescribed antibiotics for 0.65-1.36 million ARIs per year nationally, or at 11-23% of the current prescribing rate. Antibiotics were prescribed more frequently than recommended for acute rhinosinusitis, acute bronchitis/bronchiolitis, acute otitis media, and acute pharyngitis/tonsillitis.
Antibiotics are prescribed for ARIs at rates 4-9 times as high as those recommended by Therapeutic Guidelines. Our data provide the basis for setting absolute targets for reducing antibiotic prescribing in Australian general practice. To compare the current rate of antibiotic prescribing for acute respiratory infections (ARIs) in Australian general practice with the recommendations in the most widely consulted therapeutic guidelines in Australia (Therapeutic Guidelines).OBJECTIVETo compare the current rate of antibiotic prescribing for acute respiratory infections (ARIs) in Australian general practice with the recommendations in the most widely consulted therapeutic guidelines in Australia (Therapeutic Guidelines).Comparison of general practice activity data for April 2010 - March 2015 (derived from Bettering the Evaluation and Care of Health [BEACH] study) with estimated rates of prescribing recommended by Therapeutic Guidelines.DESIGN AND SETTINGComparison of general practice activity data for April 2010 - March 2015 (derived from Bettering the Evaluation and Care of Health [BEACH] study) with estimated rates of prescribing recommended by Therapeutic Guidelines.Antibiotic prescribing rates and estimated guideline-recommended rates per 100 encounters and per full-time equivalent (FTE) GP per year for eight ARIs; number of prescriptions nationally per year.MAIN OUTCOME MEASURESAntibiotic prescribing rates and estimated guideline-recommended rates per 100 encounters and per full-time equivalent (FTE) GP per year for eight ARIs; number of prescriptions nationally per year.An estimated mean 5.97 million (95% CI, 5.69-6.24 million) ARI cases per year were managed in Australian general practice with at least one antibiotic, equivalent to an estimated 230 cases per FTE GP/year (95% CI, 219-240 cases/FTE/year). Antibiotics are not recommended by the guidelines for acute bronchitis/bronchiolitis (current prescribing rate, 85%) or influenza (11%); they are always recommended for community-acquired pneumonia (current prescribing rate, 72%) and pertussis (71%); and they are recommended for 0.5-8% of cases of acute rhinosinusitis (current prescribing rate, 41%), 20-31% of cases of acute otitis media (89%), and 19-40% cases of acute pharyngitis or tonsillitis (94%). Had GPs adhered to the guidelines, they would have prescribed antibiotics for 0.65-1.36 million ARIs per year nationally, or at 11-23% of the current prescribing rate. Antibiotics were prescribed more frequently than recommended for acute rhinosinusitis, acute bronchitis/bronchiolitis, acute otitis media, and acute pharyngitis/tonsillitis.RESULTSAn estimated mean 5.97 million (95% CI, 5.69-6.24 million) ARI cases per year were managed in Australian general practice with at least one antibiotic, equivalent to an estimated 230 cases per FTE GP/year (95% CI, 219-240 cases/FTE/year). Antibiotics are not recommended by the guidelines for acute bronchitis/bronchiolitis (current prescribing rate, 85%) or influenza (11%); they are always recommended for community-acquired pneumonia (current prescribing rate, 72%) and pertussis (71%); and they are recommended for 0.5-8% of cases of acute rhinosinusitis (current prescribing rate, 41%), 20-31% of cases of acute otitis media (89%), and 19-40% cases of acute pharyngitis or tonsillitis (94%). Had GPs adhered to the guidelines, they would have prescribed antibiotics for 0.65-1.36 million ARIs per year nationally, or at 11-23% of the current prescribing rate. Antibiotics were prescribed more frequently than recommended for acute rhinosinusitis, acute bronchitis/bronchiolitis, acute otitis media, and acute pharyngitis/tonsillitis.Antibiotics are prescribed for ARIs at rates 4-9 times as high as those recommended by Therapeutic Guidelines. Our data provide the basis for setting absolute targets for reducing antibiotic prescribing in Australian general practice.CONCLUSIONSAntibiotics are prescribed for ARIs at rates 4-9 times as high as those recommended by Therapeutic Guidelines. Our data provide the basis for setting absolute targets for reducing antibiotic prescribing in Australian general practice. Objective: To compare the current rate of antibiotic prescribing for acute respiratory infections (ARIs) in Australian general practice with the recommendations in the most widely consulted therapeutic guidelines in Australia (Therapeutic Guidelines). Design and setting: Comparison of general practice activity data for April 2010 – March 2015 (derived from Bettering the Evaluation and Care of Health [BEACH] study) with estimated rates of prescribing recommended by Therapeutic Guidelines. Main outcome measures: Antibiotic prescribing rates and estimated guideline‐recommended rates per 100 encounters and per full‐time equivalent (FTE) GP per year for eight ARIs; number of prescriptions nationally per year. Results: An estimated mean 5.97 million (95% CI, 5.69–6.24 million) ARI cases per year were managed in Australian general practice with at least one antibiotic, equivalent to an estimated 230 cases per FTE GP/year (95% CI, 219–240 cases/FTE/year). Antibiotics are not recommended by the guidelines for acute bronchitis/bronchiolitis (current prescribing rate, 85%) or influenza (11%); they are always recommended for community‐acquired pneumonia (current prescribing rate, 72%) and pertussis (71%); and they are recommended for 0.5–8% of cases of acute rhinosinusitis (current prescribing rate, 41%), 20–31% of cases of acute otitis media (89%), and 19–40% cases of acute pharyngitis or tonsillitis (94%). Had GPs adhered to the guidelines, they would have prescribed antibiotics for 0.65–1.36 million ARIs per year nationally, or at 11–23% of the current prescribing rate. Antibiotics were prescribed more frequently than recommended for acute rhinosinusitis, acute bronchitis/bronchiolitis, acute otitis media, and acute pharyngitis/tonsillitis. Conclusions: Antibiotics are prescribed for ARIs at rates 4–9 times as high as those recommended by Therapeutic Guidelines. Our data provide the basis for setting absolute targets for reducing antibiotic prescribing in Australian general practice. |
| Author | Britt, Helena C Glasziou, Paul P McCullough, Amanda R Pollack, Allan J Plejdrup Hansen, Malene Looke, David FM Del Mar, Christopher B |
| Author_xml | – sequence: 1 givenname: Amanda R surname: McCullough fullname: McCullough, Amanda R – sequence: 2 givenname: Allan J surname: Pollack fullname: Pollack, Allan J – sequence: 3 givenname: Malene surname: Plejdrup Hansen fullname: Plejdrup Hansen, Malene – sequence: 4 givenname: Paul P surname: Glasziou fullname: Glasziou, Paul P – sequence: 5 givenname: David FM surname: Looke fullname: Looke, David FM – sequence: 6 givenname: Helena C surname: Britt fullname: Britt, Helena C – sequence: 7 givenname: Christopher B surname: Del Mar fullname: Del Mar, Christopher B email: CDelMar@bond.edu.au |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28701117$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUtv1DAURi1URKeFFXvkJRJK8SO2J-ymFU8VsSkSu-jGuRlcJXawHVWz46fjZgoLJFj5-up8R7K_M3Lig0dCnnN2oXRTv55ugesLxlktHpENl0JXShpzQjaMCVUZ0Xw7JWcp3ZYrV8I8Iadiaxjn3GzIz53PrnMhO5voECIFu2SkEdPsIuQQD9T5AW12wacy0j16jDDSOUJZWnxDbZhmiC4FT8NQ9phsLEq_p0WAid65_J3uF9fj6Py9ugQm9D2szqfk8QBjwmcP5zn5-u7tzdWH6vrL-49Xu-vKSqlVZU1X8171Q7dFCb3shLRaAEAPnVYNt2Cw6czARM1tI2DQmvccOqVU00PN5Dl5efTOMfxYMOV2csniOILHsKSWN3y7rbWWuqAvHtClm7Bv5-gmiIf2968V4NURsDGkFHH4g3DW3nfSrp20ayeF5n_R1uX18TmCG_-R0cfMnRvx8D99-_nTTtxcrrNW8hdOf6Mp |
| CitedBy_id | crossref_primary_10_1093_fampra_cmac052 crossref_primary_10_1186_s12887_022_03206_4 crossref_primary_10_1093_cid_ciaa874 crossref_primary_10_1093_fampra_cmaf005 crossref_primary_10_1016_j_amjoto_2020_102564 crossref_primary_10_3390_children11040444 crossref_primary_10_1016_j_bjorl_2018_02_001 crossref_primary_10_1080_02813432_2022_2036494 crossref_primary_10_1186_s12887_020_02052_6 crossref_primary_10_1177_0194599818796137 crossref_primary_10_1016_j_medine_2019_10_008 crossref_primary_10_1007_s00203_025_04382_4 crossref_primary_10_3390_ijms22073703 crossref_primary_10_1017_ice_2017_263 crossref_primary_10_1111_jpc_14560 crossref_primary_10_1136_bmjopen_2022_068193 crossref_primary_10_1136_bmjopen_2024_090190 crossref_primary_10_1016_j_sapharm_2023_02_009 crossref_primary_10_2196_60831 crossref_primary_10_3390_antibiotics9080498 crossref_primary_10_1016_j_mayocp_2018_06_011 crossref_primary_10_1093_fampra_cmad055 crossref_primary_10_1186_s40816_021_00308_x crossref_primary_10_1016_j_sapharm_2021_01_004 crossref_primary_10_1016_j_bjorl_2025_101595 crossref_primary_10_1017_ice_2022_160 crossref_primary_10_1097_HM9_0000000000000062 crossref_primary_10_1371_journal_pone_0255789 crossref_primary_10_1186_s40814_020_00671_5 crossref_primary_10_1016_j_ctcp_2020_101171 crossref_primary_10_1071_PY20115 crossref_primary_10_1071_PY22258 crossref_primary_10_1111_ijcp_14514 crossref_primary_10_1016_j_heliyon_2023_e14843 crossref_primary_10_1186_s40814_018_0337_x crossref_primary_10_1016_j_amjoto_2022_103644 crossref_primary_10_5694_mja17_00077 crossref_primary_10_1016_j_medin_2019_10_006 crossref_primary_10_1016_j_puhe_2023_12_004 crossref_primary_10_2196_40876 crossref_primary_10_1016_j_jhin_2022_09_016 crossref_primary_10_1007_s11010_020_03833_4 crossref_primary_10_1136_bmjopen_2024_094811 crossref_primary_10_1002_rmv_1995 crossref_primary_10_1186_s13756_022_01115_w crossref_primary_10_1136_bmjopen_2018_026396 crossref_primary_10_1093_ijpp_riaf009 crossref_primary_10_1186_s12879_024_09526_3 crossref_primary_10_2147_JIR_S341581 crossref_primary_10_1007_s00431_020_03790_6 crossref_primary_10_3390_antibiotics13090900 crossref_primary_10_1002_hpm_3061 crossref_primary_10_1016_j_cmi_2021_03_030 crossref_primary_10_1017_ice_2019_16 crossref_primary_10_7748_ns_2018_e11123 crossref_primary_10_1111_ppe_12870 crossref_primary_10_1093_fampra_cmy134 crossref_primary_10_1371_journal_pone_0261917 crossref_primary_10_3390_antibiotics14090914 crossref_primary_10_5694_mja2_50853 crossref_primary_10_1016_j_bjorl_2021_01_001 crossref_primary_10_1089_mdr_2020_0017 crossref_primary_10_1136_bmjopen_2018_028329 crossref_primary_10_1080_17476348_2025_2510378 crossref_primary_10_1093_ofid_ofz018 crossref_primary_10_3390_laws14010005 crossref_primary_10_5694_mja17_00382 crossref_primary_10_1186_s40816_023_00364_5 crossref_primary_10_3201_eid2705_203692 crossref_primary_10_3390_antibiotics12030594 crossref_primary_10_1016_j_ebiom_2023_104864 crossref_primary_10_1111_bcp_15000 crossref_primary_10_5694_mja17_01025 crossref_primary_10_5694_mja17_00574 crossref_primary_10_3390_jcm13195770 crossref_primary_10_1016_j_jhin_2021_01_019 crossref_primary_10_1186_s12875_024_02371_y crossref_primary_10_1186_s13104_019_4150_2 crossref_primary_10_1016_j_ebiom_2021_103538 crossref_primary_10_1016_j_japh_2020_10_014 crossref_primary_10_1155_2021_2460553 crossref_primary_10_1186_s12875_023_02123_4 crossref_primary_10_1016_j_diagmicrobio_2024_116541 crossref_primary_10_1080_13814788_2019_1674279 crossref_primary_10_1016_j_pathol_2019_04_003 crossref_primary_10_1038_s41598_025_97936_x crossref_primary_10_1093_fampra_cmz079 crossref_primary_10_1186_s12879_022_07887_1 crossref_primary_10_3390_antibiotics9120900 crossref_primary_10_1093_jacamr_dlab166 crossref_primary_10_3390_antibiotics9060310 crossref_primary_10_35339_ekm_2021_90_1_k_n |
| Cites_doi | 10.1093/jac/dkt301 10.7326/M15-1840 10.1016/j.rmed.2006.02.015 10.1093/fampra/cmw025 10.1001/jama.2016.4151 10.1111/j.1651-2227.2012.02754.x 10.1136/bmj.i3410 10.1093/jac/dkr279 10.1093/jac/dkv164 10.1016/S1473-3099(14)70780-7 |
| ContentType | Journal Article |
| Copyright | 2017 AMPCo Pty Ltd. All rights reserved |
| Copyright_xml | – notice: 2017 AMPCo Pty Ltd. All rights reserved |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.5694/mja16.01042 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1326-5377 |
| EndPage | 69 |
| ExternalDocumentID | 28701117 10_5694_mja16_01042 MJA2TB0104265 |
| Genre | article Journal Article Comparative Study |
| GrantInformation_xml | – fundername: National Health and Medical Research Council funderid: 1044904 – fundername: Centre for Research Excellence in Minimising Antibiotic Resistance from Acute Respiratory Infections |
| GroupedDBID | --- ..I .55 .GJ 0R~ 1OB 1OC 29M 33P 53G 5GY 5RE 8R4 8R5 8WZ A6W AAHQN AAIPD AAMMB AAMNL AANLZ AAQQT AASGY AAWTL AAXRX AAYCA ABCQX ABCUV ABJNI ABQWH ACAHQ ACBNA ACCZN ACGFO ACPOU ACXBN ACXQS ADBBV ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEIGN AENEX AEUYR AEYWJ AFFNX AFFPM AFGKR AFWVQ AGHNM AGXDD AGYGG AHBTC AHMBA AIDQK AIDYY AITYG AIURR ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMYDB BAWUL BCR BCU BES BFHJK BLC C45 DCZOG DRFUL DRSTM DUUFO E3Z EBS EJD EMOBN EX3 F5P HGLYW H~9 J5H L7B LATKE LEEKS LH4 LHP LYRES MEWTI MXFUL MXSTM OHT OVD P2P P2W PEA PQQKQ Q2X RJQFR ROL SAMSI SJN SUPJJ TAE TEORI UDS WH7 WOQ WOW WXSBR X7M XSB ZGI ZXP ZZTAW ~02 AAYXX CITATION 7RO AAHHS ACCFJ AEEZP AEQDE AIWBW AJBDE CGR CUY CVF ECM EIF K60 K6~ NPM 7X8 |
| ID | FETCH-LOGICAL-c3365-c7b41d5dfb8e3ad3b23c62aaadab6591ca7e9b7f0241c92af661d1ab5559da403 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 108 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000405640300009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0025-729X 1326-5377 |
| IngestDate | Fri Sep 05 10:19:21 EDT 2025 Wed Feb 19 02:36:39 EST 2025 Tue Nov 18 22:00:34 EST 2025 Sat Nov 29 01:35:01 EST 2025 Tue Sep 09 05:11:11 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Prescribing Anti-infective agents Drug resistance, microbial Primary care |
| Language | English |
| License | http://doi.wiley.com/10.1002/tdm_license_1.1 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3365-c7b41d5dfb8e3ad3b23c62aaadab6591ca7e9b7f0241c92af661d1ab5559da403 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
| PMID | 28701117 |
| PQID | 1918846636 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_1918846636 pubmed_primary_28701117 crossref_primary_10_5694_mja16_01042 crossref_citationtrail_10_5694_mja16_01042 wiley_primary_10_5694_mja16_01042_MJA2TB0104265 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-07-17 |
| PublicationDateYYYYMMDD | 2017-07-17 |
| PublicationDate_xml | – month: 07 year: 2017 text: 2017-07-17 day: 17 |
| PublicationDecade | 2010 |
| PublicationPlace | Australia |
| PublicationPlace_xml | – name: Australia |
| PublicationTitle | Medical journal of Australia |
| PublicationTitleAlternate | Med J Aust |
| PublicationYear | 2017 |
| References | 2014; 3 2013; 1 2012; 101 2013; 11 2012 2015; 70 1998 2016; 354 2011; 66 2014; 69 2014; 14 2016; 315 2015 2014 2013 2013; 6 1972; 22 2016; 164 2006; 100 2016; 33 Classification Committee of the World Organization of Family Doctors (WONCA) (e_1_2_7_12_1) 1998 e_1_2_7_5_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 Britt H (e_1_2_7_17_1) 2015 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_11_1 e_1_2_7_10_1 Kenealy T (e_1_2_7_16_1) 2013; 6 Venekamp R (e_1_2_7_14_1) 2013; 1 Spinks A (e_1_2_7_15_1) 2013; 11 Howie JG (e_1_2_7_26_1) 1972; 22 Respiratory Expert Groups (e_1_2_7_6_1) 2014 Gulliford MC (e_1_2_7_25_1) 2016; 354 e_1_2_7_24_1 e_1_2_7_23_1 e_1_2_7_21_1 e_1_2_7_20_1 Britt H (e_1_2_7_2_1) 2014 Antibiotic Expert Groups (e_1_2_7_4_1) 2014 Smith S (e_1_2_7_3_1) 2014; 3 Magin PJ (e_1_2_7_22_1) 2016; 33 WHO Collaborating Centre for Drug Statistics Methodology (e_1_2_7_13_1) 2013 28701125 - Med J Aust. 2017 Jul 17;207(2):62-63 |
| References_xml | – volume: 14 start-page: 742 year: 2014 end-page: 750 article-title: Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data publication-title: Lancet Infect Dis – volume: 22 start-page: 310 year: 1972 end-page: 315 article-title: Diagnosis — the Achilles heel? publication-title: J R Coll Gen Pract – volume: 1 start-page: CD000219 year: 2013 article-title: Antibiotics for acute otitis media in children publication-title: Cochrane Database Syst Rev – volume: 315 start-page: 1864 year: 2016 end-page: 1873 article-title: Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011 publication-title: JAMA – volume: 100 start-page: 2004 year: 2006 end-page: 2011 article-title: Antibiotic prescribing in Australian general practice: how has it changed from 1990–91 to 2002–03? publication-title: Respir Med – volume: 6 start-page: CD000247 year: 2013 article-title: Antibiotics for the common cold and acute purulent rhinitis publication-title: Cochrane Database Syst Rev – volume: 66 start-page: 2215 year: 2011 end-page: 2223 article-title: Antibiotic prescribing for acute respiratory tract infections in primary care: a systematic review and meta‐ethnography publication-title: J Antimicrob Chemother – volume: 3 start-page: CD000245 year: 2014 article-title: Antibiotics for acute bronchitis publication-title: Cochrane Database Syst Rev – volume: 164 start-page: 425 year: 2016 end-page: 434 article-title: Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high‐value care from the American College of Physicians and the Centers for Disease Control and Prevention publication-title: Ann Intern Med – year: 2012 article-title: The real story, GP prescribing of antibiotics for respiratory tract infections — from BEACH – volume: 354 start-page: 3410 year: 2016 article-title: Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health records publication-title: BMJ – volume: 33 start-page: 360 year: 2016 end-page: 367 article-title: Changes in early‐career family physicians‘ antibiotic prescribing for upper respiratory tract infection and acute bronchitis: a multicentre longitudinal study publication-title: Fam Pract – volume: 69 start-page: 234 year: 2014 end-page: 240 article-title: Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09 publication-title: J Antimicrob Chemother – volume: 70 start-page: 2465 year: 2015 end-page: 2473 article-title: Not in my backyard: a systematic review of clinicians’ knowledge and beliefs about antibiotic resistance publication-title: J Antimicrob Chemother – year: 2014 – year: 2015 – volume: 101 start-page: 935 year: 2012 end-page: 940 article-title: Antibiotic prescribing for upper respiratory infections: European primary paediatricians’ knowledge, attitudes and practice publication-title: Acta Paediatr – year: 1998 – year: 2013 – volume: 11 start-page: CD000023 year: 2013 article-title: Antibiotics for sore throat publication-title: Cochrane Database Syst Rev – volume-title: General practice activity in Australia: 2013–14 (General Practice Series No. 37) year: 2014 ident: e_1_2_7_2_1 – volume: 1 start-page: CD000219 year: 2013 ident: e_1_2_7_14_1 article-title: Antibiotics for acute otitis media in children publication-title: Cochrane Database Syst Rev – ident: e_1_2_7_9_1 doi: 10.1093/jac/dkt301 – ident: e_1_2_7_5_1 doi: 10.7326/M15-1840 – volume-title: Therapeutic guidelines: antibiotic, version 15 year: 2014 ident: e_1_2_7_4_1 – volume: 22 start-page: 310 year: 1972 ident: e_1_2_7_26_1 article-title: Diagnosis — the Achilles heel? publication-title: J R Coll Gen Pract – ident: e_1_2_7_11_1 – ident: e_1_2_7_20_1 doi: 10.1016/j.rmed.2006.02.015 – volume: 33 start-page: 360 year: 2016 ident: e_1_2_7_22_1 article-title: Changes in early‐career family physicians‘ antibiotic prescribing for upper respiratory tract infection and acute bronchitis: a multicentre longitudinal study publication-title: Fam Pract doi: 10.1093/fampra/cmw025 – ident: e_1_2_7_23_1 doi: 10.1001/jama.2016.4151 – ident: e_1_2_7_24_1 doi: 10.1111/j.1651-2227.2012.02754.x – volume-title: Therapeutic guidelines: respiratory, version 5 year: 2014 ident: e_1_2_7_6_1 – volume: 11 start-page: CD000023 year: 2013 ident: e_1_2_7_15_1 article-title: Antibiotics for sore throat publication-title: Cochrane Database Syst Rev – ident: e_1_2_7_21_1 – volume-title: ICPC‐2. International Classification of Primary Care year: 1998 ident: e_1_2_7_12_1 – volume-title: A decade of Australian general practice activity: 2005–06 to 2014–15 (General Practice Series No. 39) year: 2015 ident: e_1_2_7_17_1 – ident: e_1_2_7_19_1 – ident: e_1_2_7_18_1 – volume: 354 start-page: 3410 year: 2016 ident: e_1_2_7_25_1 article-title: Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health records publication-title: BMJ doi: 10.1136/bmj.i3410 – ident: e_1_2_7_7_1 doi: 10.1093/jac/dkr279 – volume: 3 start-page: CD000245 year: 2014 ident: e_1_2_7_3_1 article-title: Antibiotics for acute bronchitis publication-title: Cochrane Database Syst Rev – ident: e_1_2_7_8_1 doi: 10.1093/jac/dkv164 – ident: e_1_2_7_10_1 doi: 10.1016/S1473-3099(14)70780-7 – volume: 6 start-page: CD000247 year: 2013 ident: e_1_2_7_16_1 article-title: Antibiotics for the common cold and acute purulent rhinitis publication-title: Cochrane Database Syst Rev – volume-title: Guidelines for ATC classification and DDD assignment 2014 year: 2013 ident: e_1_2_7_13_1 – reference: 28701125 - Med J Aust. 2017 Jul 17;207(2):62-63 |
| SSID | ssj0021527 |
| Score | 2.5242531 |
| Snippet | Objective: To compare the current rate of antibiotic prescribing for acute respiratory infections (ARIs) in Australian general practice with the... To compare the current rate of antibiotic prescribing for acute respiratory infections (ARIs) in Australian general practice with the recommendations in the... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 65 |
| SubjectTerms | Acute Disease Anti-Bacterial Agents - therapeutic use Australia General medicine General Practice - statistics & numerical data Guideline Adherence Humans Inappropriate Prescribing - statistics & numerical data Practice Guidelines as Topic Practice Patterns, Physicians' - statistics & numerical data Primary Health Care Referral and Consultation Respiratory tract diseases Respiratory Tract Infections - classification Respiratory Tract Infections - drug therapy |
| Title | Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.5694%2Fmja16.01042 https://www.ncbi.nlm.nih.gov/pubmed/28701117 https://www.proquest.com/docview/1918846636 |
| Volume | 207 |
| WOSCitedRecordID | wos000405640300009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1326-5377 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021527 issn: 0025-729X databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LTxsxEB5BQIgLhfJoaEFG4lQpkH3Za25pS4QQIIRAym3l10ZUzabKJj33pzPj3SxQKiTEbQ9-rDy25xvPzDcAh1T0zSlHyA3FEDurOzp0upNKbfJERlYazzN7Ia6u0sFAXtexOZQLU_FDNA9udDL8fU0HXGlfhSThMkYhjn6qgB-ROYE38FKIOzdpwdKPm_7dRWNx_VuztUrQowGOn3R_rpJe4MznsNXrnf6Hd_7xOqzVgJP1qh2yAQuu-Agrl7VLfRP-9gpKGxkTXTNDBMuUmU0dmzy64Nk8YKso8ZMNK6JqNs-vOmGmqWXIxjmjyFq8itDiHjLioSgZvfWy4YwItXBKRjb4aOTqak7lFtz1T2-_n3XqsgwdE1FMnBE6Dmxic526SNlIh5HhoVLKKs0TGRglnNQiR-0fGBmqHCGADZRO0HixKu5G29AqxoX7BMxyKVFwkejGIja5Voa70BiE0l1hu0K14etcMpmpOcupdMavDG0XWtXMr2nm17QNh03j3xVVx_-bHcxFnOFRIv-IKtx4VmZouqYIx3jE27BTyb4ZiPzBqBZEG469iF-bIbs874W33_w3T3bf3OMzrIYEHjx95xdoTScztwfL5s_0vpzsw6IYpPv1Tn8A8MIB7g |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9tAEB5VgIBLobyaQmGROCGFxK_dLLdAG0FJIoSCxM3al6NWjVPFSc_96Z2xHfMUEuLmwz6snZ2Zb3Z3vgE4oqJvTjlCbiiG0Fld177T9ZbUJolkYKXJeWa7ot9v3d3J6_LAjXJhCn6I6sCNNCO316TgdCBNWh5xGaIUR7-Ux08onkATvBjiRsIdvvjtpnPbrUKup0Vbiww9GqDxoPtjn_QMaD7Grbnj6ay995fX4WMJOVm72COf4INLN2C5V16qb8K_dkqJI2MibGaIYZkys6ljk_tLeDZ_spVm-MmGBVU1m2dYnTJTVTNk44TR21o0RhhzDxkxUWSMTnvZcEaUWjgloyh8NHJlPadsC2473wfnF_WyMEPdBPQqzggdejayiW65QNlA-4HhvlLKKs0j6RklnNQiQf_vGemrBEGA9ZSOMHyxKmwG27CQjlP3GZjlUqLRCUQzFKFJtDLc-cYgmG4K2xSqBsdz0cSmZC2n4hm_Y4xeaFXjfE3jfE1rcFQ1_lOQdbzc7HAu4xiViW5IVOrGsyzG4LWFgIwHvAY7hfCrgehGGB2DqEEjl_FrM8S9H21_cJZ_8-jLm3scwMrFoNeNu5f9q11Y9QlK5GSee7AwnczcV1gyf6c_s8l-ueH_A0WBBPY |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dbxJBEJ8Yaogvtmpb0WrXhCcTWu5rl_WNFklVIMRAwttlv460kYNw0Of-6Z25O06rponx7R7247KzM_ubnZ3fADSp6JtTjpAbiiF0Vre073SrI7VJIhlYaXKe2YEYjTqzmRyXF26UC1PwQ1QXbqQZub0mBXcrm5CWR1yGKMXFjfL4GfkTaIL3QiojU4O93vf-dFC5XL8XbS0y9GiA81-6PzyT_gCaD3FrfvD09__3lw_geQk5WbfYIy_giUtfQn1YBtVfwV03pcSRJRE2M8SwTJntxrH1zyA82z3ZSjP8ZPOCqprtMqw-MVNVM2TLhNHbWjRG6HPPGTFRZIxue9l8S5RaOCUjL3yxcGU9p-wQpv3Pk8urVlmYoWUCehVnhA49G9lEd1ygbKD9wHBfKWWV5pH0jBJOapHg-e8Z6asEQYD1lI7QfbEqbAdHUEuXqXsNzHIp0egEoh2K0CRaGe58YxBMt4VtC9WAjzvRxKZkLafiGT9i9F5oVeN8TeN8TRvQrBqvCrKOvzf7sJNxjMpEERKVuuU2i9F57SAg4wFvwHEh_GogigjjwSAacJ7L-LEZ4uHXrj-5yL959Oafe5xCfdzrx4Mvo29v4ZlPSCLn8jyB2ma9de_gqbndXGfr9-V-vwfKfARx |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibiotics+for+acute+respiratory+infections+in+general+practice%3A+comparison+of+prescribing+rates+with+guideline+recommendations&rft.jtitle=Medical+journal+of+Australia&rft.au=McCullough%2C+Amanda+R&rft.au=Pollack%2C+Allan+J&rft.au=Plejdrup+Hansen%2C+Malene&rft.au=Glasziou%2C+Paul+P&rft.date=2017-07-17&rft.eissn=1326-5377&rft.volume=207&rft.issue=2&rft.spage=65&rft_id=info:doi/10.5694%2Fmja16.01042&rft_id=info%3Apmid%2F28701117&rft.externalDocID=28701117 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-729X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-729X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-729X&client=summon |